Cargando…
New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination
Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536917/ https://www.ncbi.nlm.nih.gov/pubmed/34687421 http://dx.doi.org/10.1007/s12185-021-03243-2 |
_version_ | 1784588125216964608 |
---|---|
author | Hidaka, Daisuke Ogasawara, Reiki Sugimura, Shunsuke Fujii, Fumiaki Kojima, Keisuke Nagai, Jun Ebata, Ko Okada, Kohei Kobayashi, Naoki Ogasawara, Masahiro Imamura, Masahiro Ota, Shuichi |
author_facet | Hidaka, Daisuke Ogasawara, Reiki Sugimura, Shunsuke Fujii, Fumiaki Kojima, Keisuke Nagai, Jun Ebata, Ko Okada, Kohei Kobayashi, Naoki Ogasawara, Masahiro Imamura, Masahiro Ota, Shuichi |
author_sort | Hidaka, Daisuke |
collection | PubMed |
description | Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccination in a 53-year-old woman. Blood examination at diagnosis showed hemolytic anemia with a positive Coombs test and thrombocytopenia. Hypocomplementemia and the presence of lupus anticoagulant indicated a strong association with SLE. Prednisolone administration rapidly restored hemoglobin level and platelet count. This case suggests that mRNA COVID-19 vaccination may cause an autoimmune disorder. Physicians should be aware of this adverse reaction by mRNA COVID-19 vaccination and should consider the benefits and risks of vaccination for each recipient. |
format | Online Article Text |
id | pubmed-8536917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Singapore |
record_format | MEDLINE/PubMed |
spelling | pubmed-85369172021-10-25 New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination Hidaka, Daisuke Ogasawara, Reiki Sugimura, Shunsuke Fujii, Fumiaki Kojima, Keisuke Nagai, Jun Ebata, Ko Okada, Kohei Kobayashi, Naoki Ogasawara, Masahiro Imamura, Masahiro Ota, Shuichi Int J Hematol Case Report Evans syndrome presents as concurrent autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Systemic lupus erythematosus (SLE) is the most frequent autoimmune disorder associated with Evans syndrome. We herein report a case of new-onset Evans syndrome associated with SLE after BNT162b2 mRNA coronavirus disease 2019 (COVID-19) vaccination in a 53-year-old woman. Blood examination at diagnosis showed hemolytic anemia with a positive Coombs test and thrombocytopenia. Hypocomplementemia and the presence of lupus anticoagulant indicated a strong association with SLE. Prednisolone administration rapidly restored hemoglobin level and platelet count. This case suggests that mRNA COVID-19 vaccination may cause an autoimmune disorder. Physicians should be aware of this adverse reaction by mRNA COVID-19 vaccination and should consider the benefits and risks of vaccination for each recipient. Springer Singapore 2021-10-23 2022 /pmc/articles/PMC8536917/ /pubmed/34687421 http://dx.doi.org/10.1007/s12185-021-03243-2 Text en © Japanese Society of Hematology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Case Report Hidaka, Daisuke Ogasawara, Reiki Sugimura, Shunsuke Fujii, Fumiaki Kojima, Keisuke Nagai, Jun Ebata, Ko Okada, Kohei Kobayashi, Naoki Ogasawara, Masahiro Imamura, Masahiro Ota, Shuichi New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination |
title | New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination |
title_full | New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination |
title_fullStr | New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination |
title_full_unstemmed | New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination |
title_short | New-onset Evans syndrome associated with systemic lupus erythematosus after BNT162b2 mRNA COVID-19 vaccination |
title_sort | new-onset evans syndrome associated with systemic lupus erythematosus after bnt162b2 mrna covid-19 vaccination |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536917/ https://www.ncbi.nlm.nih.gov/pubmed/34687421 http://dx.doi.org/10.1007/s12185-021-03243-2 |
work_keys_str_mv | AT hidakadaisuke newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT ogasawarareiki newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT sugimurashunsuke newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT fujiifumiaki newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT kojimakeisuke newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT nagaijun newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT ebatako newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT okadakohei newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT kobayashinaoki newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT ogasawaramasahiro newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT imamuramasahiro newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination AT otashuichi newonsetevanssyndromeassociatedwithsystemiclupuserythematosusafterbnt162b2mrnacovid19vaccination |